Mute Ventures

Mute Ventures Research

Investment Thesis

Mute Ventures is a New York- and Los Angeles-based venture firm founded in 2023 by Chris Quinn. Its stated ethos is "trust is the access": the firm believes the strongest rounds are often won before they are formally raised, and it sources deals through relationship-led networks rather than broad outbound. Mute backs companies from early stage through growth, with a stated focus on AI infrastructure, AI applications, defense, and frontier technology, extending into robotics and space in its broader portfolio (per its own portfolio-page description: "Companies across AI, defense, frontier technology, robotics, space, and beyond"). The firm operates one platform, two strategies, giving it a full-lifecycle view of category-defining founders from Day 0 through pre-IPO growth and secondaries.

Stage Focus

Mute runs two coordinated strategies:

• Early stage: pre-seed and seed, backing founders "at the beginning, when conviction matters most."
• Growth: Series B through pre-IPO, executed as primary and secondary investments concentrated in AI, defense, and frontier technology.

SEC fund-vehicle filings show at least two raised vehicles (Fund I and Fund II, a series of Mute Ventures, LP), consistent with an actively deploying early-stage program alongside the newer growth/secondaries strategy led out of Los Angeles.

Check Size

Mute does not publish check-size ranges on its site. A third-party syndicate tracker (Superscout) estimates a typical early-stage investment size near $105K per deal, consistent with a multi-manager seed/pre-seed program that writes many smaller checks rather than large solo leads. The growth strategy, by contrast, is explicitly built around primary and secondary positions in later-stage rounds (Series B to pre-IPO), which implies materially larger per-transaction sizes than the early-stage program. Given the split strategy and lack of a single published range, no single check-size figure is reliable enough to report with confidence.

Lead Tendency

Public deal coverage (e.g., the HavocAI $100M Series A, May 2026) shows Mute Ventures participating alongside a large syndicate of other investors (CCM Capital Markets, Clear Street, Cobalt Capital, Boardman Bay Capital Management, Meet Perry, and others), rather than leading. Combined with the firm's stated approach of "earning access" as companies grow, Mute's public profile reads as a participant/follow-on investor in most rounds rather than a round leader, though it may lead smaller early-stage checks where it has the earliest relationship. Overall tendency: unclear/mixed, leaning toward participating in syndicates.

Recent Activity

Mute Ventures appears to be actively deploying across both its early-stage and growth strategies:

• May 2026: Participated in HavocAI's $100M Series A for autonomous maritime defense vessels, alongside a large syndicate including CCM Capital Markets, Clear Street, Cobalt Capital, Boardman Bay Capital Management, and Meet Perry.
• April 2026: Portfolio company Hypercard (Hyper), an agentic expense-management startup, was acquired by American Express — an exit for Mute's early-stage book.
• Fund vehicles on file with the SEC (Fund I and Fund II, a series of Mute Ventures, LP) indicate continued fundraising and deployment through at least mid-2025.

Portfolio Highlights

Mute's public portfolio page lists 47 companies spanning AI infrastructure and applications, defense/aerospace, healthcare, fintech, and vertical SaaS, including:

• HavocAI — autonomous maritime defense vessels; raised a $100M Series A in May 2026.
• General Intuition — frontier AI lab building spatial-temporal reasoning models; raised a $133.7M seed in October 2025 (Mute's role in that specific round is not independently confirmed by primary press).
• American Turbines — small gas turbines for rapid power/orbital systems.
• Hypercard (Hyper) — agentic AI expense management, acquired by American Express (announced April 2026).
• Polymer.fyi — the firm's own portfolio page marks this company as an exit to Perplexity (no independent press confirmation found).
• Healthcare names: Candor Health, Marble Health, Photon Health, E9 Genomics.
• Enterprise/AI-tooling names: Delphi, Essence, Omen AI, Outset.ai, SellScale, Superconnector (Mute's own network/GTM platform for founders), Interface, Lapis, Novella, Draftboard, Receive, Revive, Sidekick, Pinnacle, Planmonster, Pocketshop, Montra, Crossterra, Human.

Team

• Chris Quinn — Founder & GP, New York. Founded Mute Ventures and works with companies from their earliest stages; focused on backing founders at the beginning and building lasting relationships across the portfolio.
• Blaine Davis — GP, New York. Works across the Mute portfolio with a focus on company building and product; partners with founders as they shape their businesses through early growth.
• Zach Veenstra — GP, Mute Growth, Los Angeles. Leads Mute's growth and secondaries strategy across AI, defense, and frontier technology. Previously founded Employee Capital Partners, financing liquidity for private-company shareholders.

Decision Process

Not explicitly disclosed. With three named GPs split across two coordinated but distinct strategies (early-stage vs. growth/secondaries) and general contact routed through a single partner email, the process reads as a small partnership rather than a solo-GP or formal investment-committee structure.

Founder Preferences

Mute's language ("high-octane founders," "generation-defining companies," "undiscovered ... founders at Day 0") signals a preference for technical, ambitious founders working in categories not yet obviously hot — the firm frames its edge as finding conviction "before the signal is obvious." Beyond capital, Mute emphasizes go-to-market support through its affiliated platform Superconnector, which provides customer introductions, strategic relationships, and hands-on GTM guidance — suggesting a preference for founders who will actively use a hands-on network rather than pure passive-capital seekers.

Geographic Focus

Built across New York City and Los Angeles, with NYC housing the early-stage practice (Chris Quinn, Blaine Davis) and LA housing the growth/secondaries strategy (Zach Veenstra). Portfolio companies are concentrated in the US, with no explicit stated international mandate.